Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Currency
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Solid Biosciences (SLDB)
NASDAQ:SLDB
Solid Biosciences (SLDB) Stock Price & Analysis
431 Followers
SLDB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.81 - $8.20
Previous Close$5.76
Volume1.11M
Average Volume (3M)469.29K
Market Cap
$69.01M
Enterprise Value-$48.84M
Total Cash (Recent Filing)$142.88M
Total Debt (Recent Filing)$25.04M
Price to Earnings (P/E)-1.2
Beta1.77
Next Earnings
Mar 13, 2024EPS Estimate
-$1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.61
Shares Outstanding20,177,440
10 Day Avg. Volume1,241,542
30 Day Avg. Volume469,285
Standard Deviation0.30
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.48
Price to Sales (P/S)14.36
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-94.47
Enterprise Value/Gross Profit-6.03
Enterprise Value/Ebitda0.44
Forecast
1Y Price Target
$7.33Price Target Upside44.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Solid Biosciences News
Ownership Overview
0.00% Insiders
2.03% Mutual Funds
78.05% Other Institutional Investors
19.92% Public Companies and
Individual Investors
SLDB FAQ
What was Solid Biosciences’s price range in the past 12 months?
Solid Biosciences lowest stock price was $1.81 and its highest was $8.20 in the past 12 months.
What is Solid Biosciences’s market cap?
Currently, no data Available
When is Solid Biosciences’s upcoming earnings report date?
Solid Biosciences’s upcoming earnings report date is Mar 13, 2024 which is in 93 days.
How were Solid Biosciences’s earnings last quarter?
Solid Biosciences released its earnings results on Nov 08, 2023. The company reported -$1.05 earnings per share for the quarter, beating the consensus estimate of -$1.182 by $0.132.
Is Solid Biosciences overvalued?
According to Wall Street analysts Solid Biosciences’s price is currently Undervalued.
Does Solid Biosciences pay dividends?
Solid Biosciences does not currently pay dividends.
What is Solid Biosciences’s EPS estimate?
Solid Biosciences’s EPS estimate is -$1.02.
How many shares outstanding does Solid Biosciences have?
Solid Biosciences has 20,177,440 shares outstanding.
What happened to Solid Biosciences’s price movement after its last earnings report?
Solid Biosciences reported an EPS of -$1.05 in its last earnings report, beating expectations of -$1.182. Following the earnings report the stock price went down -23.656%.
Which hedge fund is a major shareholder of Solid Biosciences?
Among the largest hedge funds holding Solid Biosciences’s share is Perceptive Advisors LLC. It holds Solid Biosciences’s shares valued at 9M.
---
Solid Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.33 (44.86% Upside)
$7.33 (44.86% Upside)
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.72%
12-Months-Change
Fundamentals
Return on Equity
-63.16%
Trailing 12-Months
Asset Growth
0.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Solid Biosciences
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding SLDB
Vanguard Total Stock Market ETF
$386.54K
Up to five ETFs with an Outperform Smart Score that hold SLDB. The ETFs are listed according to market value of SLDB within the ETF
---